Australia's most trusted
source of pharma news
Friday, 23 May 2025
Posted 21 May 2025 PM
The veil is lifting on Donald Trump's Most Favoured Nation (MFN) policy with newly-released criteria putting Australia's drug prices firmly in the US President's sights.
Yesterday the US Department of Health and Human Services (HHS), issued a media release headlined: "HHS, CMS (Centers for Medicare, Medicaid Services) set Most Favoured Nation Pricing Target to End Global Freeloading on American Patients".
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.